SHARE

Alkaline Water Company Inc (OTCMKTS:WTER) has been the center of attention in the beverage industry. The company’s consistent progress has caught attention of three of the biggest beverage companies, Coca Cola, Pepsi and Dr. Pepper, which could be eyeing an acquisition. Alkaline Water has been a lot in the news lately, mainly because of the progress it has been making. Additionally, the market trend has also been in the favor of Alkaline Water, since bottled water rose to become the second most packaged beverage being consumed in the US.

Subsequently, in the last one year WTER experienced a triple digit sales growth. Looking at the history of the beverage industry, analysts believe that at least one of the Big 3 companies is sure to look towards acquiring WTER. Additionally, history also shows that Coca-Cola is the only one in the big three that takes special interest in water companies. Hence Coca-Cola seems to be the lead name in the list of potential acquirers.

As the company nears its 4Q2015 filing, due at the end of June, interest in the company has been growing exponentially. Additionally, Coca-Cola has been experiencing a decline in the sale of soft drinks, much of which could be due to the growing interest in ionized water. It is estimated that bottled water would overtake carbonated drinks as the top beverage being consumed in the US. At the moment, ionized water accounts for $100 million in sales. At the same time, WTER’s Alakaline88 has been expanding and is projected to report $10 million annually.

It is important to note here that Alkaline Water Company also makes use of its proprietary electrolysis process to produce ionized water. This would mean that whichever of the Big 3 would acquire WTER, would possess the unique technology too.

Alkaline Water Company Inc (OTCMKTS:WTER) registered a loss 3.85% in share value, after trading just 655,481 shares in the market to reach at $0.100 in the current trading session.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

https://www.journaltranscript.com/disclaimer

LEAVE A REPLY